Comparable stake leader
B Group, Inc.
SEC ownership of NRX Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001719406.
Disclosed value leader
B Group, Inc.
Comparable rows
2/50
Latest evidence
30 Jun 2026
- Public ticker
- NRXP on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
B Group, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
B Group, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001719406
- Issuer location
- Wilmington, DE
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of NRX Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
B Group, Inc.
Disclosed value leader
B Group, Inc.
Comparable rows
2/50
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 13%
48 rows are not safely comparable across share classes.
13D/G row: B Group, Inc.
Showing 1-8 of 50 holder rows.
Quick read
B Group, Inc. leads the comparable SEC ownership view at 13%.
2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens B Group, Inc.'s linked filing trail.
Comparable ownership
Top 2
B Group, Inc.
13%
Anson Funds Management LP
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| B Group, Inc. |
13F
13D/G
3/4/5
Company · The B Group, Inc. · 10%+ Owner
|
13%
Reported 13D/G
· 18 Aug 2025
|
$16,735,327
4,091,767 shares
|
— | 30 Jun 2026 |
| Anson Funds Management LP |
13D/G
|
4.9%
Reported 13D/G
· 31 Mar 2026
|
$3,855,556
1,736,737 shares
|
+$292,512 | 31 Mar 2026 |
| Daniel C. Javitt |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,082,170
9,634,793 shares
|
— | 29 Nov 2022 |
| Jonathan C. Javitt |
3/4/5
Chairman and Chief Scientist, Director, 10%+ Owner
|
—
mixed-class rows
|
$1,774,696
1,641,834 shares
mixed-class rows
|
— | 09 Apr 2025 |
| BRAC Lending Group LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$188,880
590,435 shares
|
— | 24 May 2021 |
| Big Rock Partners Sponsor, LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$166,129
619,315 shares
mixed-class rows
|
— | 24 May 2021 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$6,618,270
1,618,159 shares
|
— | 30 Jun 2026 |
| AMERIPRISE FINANCIAL INC |
13F
Company
|
—
denominator unverified
|
$3,798,498
928,728 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 20 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 22 reporting-owner rows connected to NRX Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
22
Largest Forms 3/4/5 holder
B Group, Inc.
Net 12M change
$0
Latest report
27 Jan 2026
Recent insider transactions for NRX Pharmaceuticals, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Joseph M. Casper | NRXP | Stock Option (right to buy) | Award | 100,000 | 100,000 | 27 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.